Okada Munemasa, Nakashima Yoshiteru, Nomura Takafumi, Miura Toshiro, Nao Tomoko, Yoshimura Masayuki, Sano Yuichi, Matsunaga Naofumi
Department of Radiology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Department of Radiology, Yamaguchi Grand Hospital, Yamaguchi, Japan.
J Cardiol. 2015 Mar;65(3):230-6. doi: 10.1016/j.jjcc.2014.05.012. Epub 2014 Jun 30.
Sublingual nitroglycerin capsules or spray is routinely used to treat anginal attacks and to maximally dilate the epicardial coronary arteries during coronary angiography. These dilated coronary vessels have an advantage, but increased heart rates were disadvantageous for coronary computed tomography angiography (CTA).
The influence of applying nitroglycerin was analyzed regarding the coronary diameter, coronary luminal attenuation, evaluable number of coronary segments, heart rate (HR), HR variability, the optimal reconstruction phase, and image scoring of CTA in the same patients using a 64-slice dual-source CT.
Fifty-two patients with atypical chest pain underwent coronary CTA before and after the administration of sublingual nitroglycerin without heart rate control. The coronary diameter and luminal attenuation were measured on short-axial images in each coronary segment. The coronary vasodilation ratios (VRs) were calculated from the coronary diameters at the same location before and after the use of nitroglycerin. The local institutional review board approved this study and written informed consent was obtained from all the patients.
No significant differences were noted in the HR variability or optimal reconstruction phase, despite an increase in HR after the use of nitroglycerin. Nitroglycerin significantly enlarged the coronary artery diameter, and VRs of each coronary segment ranged from 7.54% to 22.26%. As compared with baseline coronary diameter, VRs of minor segments (16.91%) were significantly larger than those of major segments (11.35%), and the magnitude of VR correlated with the baseline coronary diameter (r=-0.48, p<0.001). Coronary luminal attenuation significantly increased due to additional administration of contrast material after the use of nitroglycerin (p<0.01), but no significant difference was noted in the image quality after the use of nitroglycerin.
Sublingual nitroglycerin significantly enlarged the coronary diameters, especially in peripheral small coronary arteries, and increased the evaluable number of coronary segments on coronary CTA.
舌下硝酸甘油胶囊或喷雾剂常用于治疗心绞痛发作,并在冠状动脉造影期间使心外膜冠状动脉最大程度扩张。这些扩张的冠状动脉有其优势,但心率增加对冠状动脉计算机断层扫描血管造影(CTA)不利。
使用64层双源CT分析同一患者应用硝酸甘油对冠状动脉直径、冠状动脉管腔衰减、可评估冠状动脉节段数、心率(HR)、HR变异性、最佳重建期以及CTA图像评分的影响。
52例非典型胸痛患者在未控制心率的情况下,于舌下含服硝酸甘油前后接受冠状动脉CTA检查。在每个冠状动脉节段的短轴图像上测量冠状动脉直径和管腔衰减。根据使用硝酸甘油前后同一位置的冠状动脉直径计算冠状动脉扩张率(VR)。本研究获得当地机构审查委员会批准,并获得所有患者的书面知情同意书。
尽管使用硝酸甘油后心率增加,但HR变异性或最佳重建期无显著差异。硝酸甘油显著增大了冠状动脉直径,各冠状动脉节段的VR在7.54%至22.26%之间。与基线冠状动脉直径相比,小节段的VR(1,691%)显著大于大节段的VR(1,135%),且VR的大小与基线冠状动脉直径相关(r = -0.48,p < 0.001)。使用硝酸甘油后,由于额外注射造影剂,冠状动脉管腔衰减显著增加(p < 0.01),但使用硝酸甘油后的图像质量无显著差异。
舌下硝酸甘油显著增大了冠状动脉直径,尤其是外周小冠状动脉,并增加了冠状动脉CTA上可评估的冠状动脉节段数。